Search Records

Briefing packages prepared for the purpose of enabling a new Minister or Deputy Minister to assume their new responsibilities, Overview of the Health Portfolio and its five organizations, Covid overview, First 100 days, Pocket book with Health Portfolio highlights,

Health Canada’s Canadian Radiological Monitoring Network (CRMN) is a national network that routinely collects environmental samples for radioactivity analysis. More information about the CRMN can be found here:...

The Public Health Agency of Canada’s (PHAC) COVID-19 immunization recommendations for individuals previously vaccinated with COVID-19 vaccines not authorized by Health Canada is intended to support local, territorial, and provincial, decision-making by public health departments and health care...

At Health Canada our role is to help Canadians maintain and improve their health. While the provinces and territories are responsible for delivering healthcare to the majority of Canadians, the federal government also has a number of key roles and responsibilities in areas that affect health and...

The Office of Audit and Evaluation (OAE) Departmental Evaluation Plan for PHAC describes the Program Evaluation Division's scheduled work for the five-year period from 2021-22 to 2025-26. The Plan was developed to meet PHAC's commitments under the Policy on Results (2016), which requires that...

The Public Health Agency of Canada (PHAC) launched the Vaccine Community Innovation Challenge on March 8, 2021, to seek creative ideas for community-based information initiatives. This is the Backgrounder for the Funding Recipients.

In May 2021, international reports of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining around the heart) following vaccination with COVID-19 mRNA vaccines emerged, including from Israel and the United States. Follow-up on these cases is ongoing. No clear...

President meeting with Mr. Stephen Lucas, Deputy Minister, Health Canada, October 11, 2019

The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post-market pharmacovigilance. This collective statement on COVID-19 vaccines...

Health Canada will also continue to identify and acquire COVID-19 treatments and therapies; expedite regulatory reviews of drugs, medical devices and disinfectants; procure any needed medical and personal protective equipment; prioritize the review of COVID-19 tests, including new, innovative...